The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of Cardiology

Abstract

1 1.Preamble mal presentations.The speakers were chosen for their particular competence in the relevant field.Furthermore, The Policy Conference on The Potential for QT selected topics were discussed in detail in separate work-Prolongation and Pro-arrhythmia by Non-anti-arrhythmic shops.This document represents the executive summary of Drugs.